BDBM419274 US10457685, Example 3::[2-({5-tert-Butyl-7-[(3S)-3-hydroxypyrrolidin-1-yl]-3H-[1,2,3]1 triazolo[4,5-d]pyrimidin-3-yl}methyl)phenyl]methanesulfonyl fluoride

SMILES CC(C)(C)c1nc(N2CC[C@H](O)C2)c2nnn(Cc3ccccc3CS(F)(=O)=O)c2n1

InChI Key InChIKey=CMLRXIOUWJKMAH-HNNXBMFYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 419274   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM419274(US10457685, Example 3 | [2-({5-tert-Butyl-7-[(3S)-...)
Affinity DataKi:  283nMAssay Description:he affinity of the compounds of the invention for cannabinoid receptors was determined using recommended amounts of membrane preparations (PerkinElme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM419274(US10457685, Example 3 | [2-({5-tert-Butyl-7-[(3S)-...)
Affinity DataKi: >1.00E+4nMAssay Description:he affinity of the compounds of the invention for cannabinoid receptors was determined using recommended amounts of membrane preparations (PerkinElme...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent